Abed et al
Injected DSIP has been shown to improve locomotor function, psychological parameters, and reduced lethality of stroke
This comparison is mechanistically distinct from IGF-1 LR3 vs MGF (ID 77399, which covers local satellite cell biology versus systemic signalling), the CJC-1295 muscle post (ID 77296, which covers GH axis and protein synthesis in depth), and the GH secretagogue hub (ID 77059) this comparison focuses specifically on the mechanistic differences in how each compound reaches and activates skeletal muscle IGF-1R, the downstream signalling divergences, and what this means for muscle research protocol design
Other Popular Peptides in the Gray Zone: Thymosin Alpha-1 Immune support (approved in 35+ countries, NOT in US) GHK-Cu (Copper Peptide) Skin/hair (injectable form banned by FDA) Epitalon Claimed anti-aging (no human studies) LL-37 Antimicrobial (research only) AOD-9604 Fat loss (FDA banned) Semorelin Growth hormone release Melanotan II Tanning (serious side effects) The FDA Crackdown: What Happened in Late 2023 Timeline of the Ban: 2023: FDA adds 12+ peptides to "Category 2 Bulk Drug Substances" list What this means: Compounding pharmacies CANNOT legally make these peptides FDA cites "significant safety risks" No approved use in humans Peptides specifically banned from compounding: BPC-157 TB-500 (Thymosin Beta-4 fragment) Thymosin Alpha-1 CJC-1295 Ipamorelin AOD-9604 GHK-Cu (injectable) Epitalon LL-37 DSIP KPV Selank Semax And more
Receptor Structure and Activation ERRs share the typical nuclear receptor domain structure, with an N-terminal activation domain, a central DNA-binding domain, and a C-terminal ligand-binding domain (LBD)
" I have seen that Semaglutide reduces the brain's reward feeling in the appetite parts
